Diplomat Pharmacy Inc  

(Public, NYSE:DPLO)   Watch this stock  
Find more results for DPLO
23.02
-0.89 (-3.72%)
After Hours: 23.02 0.00 (0.00%)
Feb 22, 4:34PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 22.95 - 24.35
52 week 13.39 - 27.78
Open 23.96
Vol / Avg. 542,266.00/892,135.00
Mkt cap 1.59B
P/E 199.00
Div/yield     -
EPS 0.12
Shares 68.87M
Beta 1.05
Inst. own 72%
Feb 26, 2018
Q4 2017 Diplomat Pharmacy Inc Earnings Call - 5:00PM EST - Add to calendar
Feb 26, 2018
Q4 2017 Diplomat Pharmacy Inc Earnings Release - 4:00PM EST - Add to calendar
Jan 10, 2018
Diplomat Pharmacy Inc at JPMorgan Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin 0.09% 0.57%
Operating margin 0.21% 1.07%
EBITD margin - 2.20%
Return on average assets 0.34% 2.38%
Return on average equity 0.64% 5.02%
Employees 1,737 -
CDP Score - -

Address

4100 S Saginaw St
FLINT, MI 48507-2683
United States - Map
+1-888-7204450 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Diplomat Pharmacy, Inc. (Diplomat) operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The Company operates through specialty pharmacy services segment. The Company's primary focus is on medication management programs for individuals with chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialty infusion therapy, and various other serious and/or long-term conditions. The Company provides specialty pharmacy support services to a national network of retailers and independent pharmacy groups, hospitals and health systems. The Company offers various services, such as specialty drug dispensing, retail specialty services, hospital and health system services, and hub services. The Company's patient care system is used to coordinate and track patient adherence and safety.

Officers and directors

Benjamin Wolin Chairman of the Board
Age: 42
Bio & Compensation  - Reuters
Joel Saban President
Age: 50
Bio & Compensation  - Reuters
Atul Kavthekar Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
Robyn Peters Executive Vice President of Sales and Payor Strategies
Bio & Compensation  - Reuters
Gary Rice Executive Vice President - Operations
Age: 59
Bio & Compensation  - Reuters
Philip R. Hagerman Chairman Emeritus
Age: 64
Bio & Compensation  - Reuters
Regina M. Benjamin M.D. Independent Director
Age: 60
Bio & Compensation  - Reuters
David C. Dreyer CPA Independent Director
Age: 60
Bio & Compensation  - Reuters
Kenneth O. Klepper Independent Director
Age: 63
Bio & Compensation  - Reuters
Shawn Cline Tomasello Independent Director
Age: 58
Bio & Compensation  - Reuters